Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation

Journal of Thrombosis and Thrombolysis

Volumn 33, Issue 4, 2012, Pages 383-388

  Acevedo, Mónica ^a   Corbalán, Ramón ^a   Braun, Sandra ^a   Pereira, Jaime ^a   González, Ilse ^a   Navarrete, Carlos ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b DEPARTAMENTO DE BIOLOGÍA   (Chile)

Author keywords

Atrial fibrillation; C reactive protein; Cardiac biomarkers; Cardiac rhythm; Soluble thrombomodulin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; PADGEM PROTEIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOMODULIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON VALVULAR ATRIAL FIBRILLATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SINUS RHYTHM; THROMBOCYTE ACTIVATION; THROMBOSIS;

EID: 84875056395     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0690-1     Document Type: Article

References (36)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98(10):946-952
2. Lip GY (1997) Hypercoagulability and haemodynamic abnormalities in atrial fibrillation. Heart 77(5):395-396
3. Lip GY, Lip PL, Zarifis J, Watson RD, Bareford D, Lowe GD, Beevers DG (1996) Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation 94(3):425-431
4. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N (1990) Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 16(2):377-380
5. Al-Saady NM, Sopher M (2001) Prothrombotic markers in atrial fibrillation: what is new? Eur Heart J 22(18):1635-1639
6. Conway DS, Heeringa J, Van Der Kuip DA, Chin BS, Hofman A, Witteman JC, Lip GY (2003) Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study. Stroke 34(2):413-417
7. Li-Saw-Hee FL, Blann AD, Lip GY (2000) A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. J Am Coll Cardiol 35(7):1926-1931
8. Lip GY, Lowe GD, Rumley A, Dunn FG (1995) Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J 73(6):527-533
9. Marin F, Roldan V, Climent VE, Ibanez A, Garcia A, Marco P, Sogorb F, Lip GY (2004) Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation. Heart 90(10):1162-1166
10. Acevedo M, Corbalan R, Braun S, Pereira J, Navarrete C, Gonzalez I (2006) C-reactive protein and atrial fibrillation: evidence for the presence of inflammation in the perpetuation of the arrhythmia. Int J Cardiol 108(3):326-331
11. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR (2001) C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104(24):2886-2891
12. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK (2003) Inflammation as a risk factor for atrial fibrillation. Circulation 108(24):3006-3010
13. Verdejo H, Roldan J, Garcia L, Del Campo A, Becerra E, Chiong M, Mellado R, Garcia A, Zalaquett R, Braun S, Garayar B, Gonzalez S, Lavandero S, Corbalan R (2011) Systemic vascular cell adhesion molecule-1 predicts the occurrence of post-operative atrial fibrillation. Int J Cardiol 150(3):270-276
14. Kamiyama N (1998) Expression of cell adhesion molecules and the appearance of adherent leukocytes on the left atrial endothelium with atrial fibrillation: rabbit experimental model. Jpn Circ J 62(11):837-843
15. Roldan V, Marin F, Blann AD, Garcia A, Marco P, Sogorb F, Lip GY (2003) Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 24(14): 1373-1380
16. Rifai N, Tracy RP, Ridker PM (1999) Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45(12):2136-2141
17. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448-454
18. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, Wildevuur CR, Eijsman L, Trouwborst A, Hack CE (1997) Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96(10):3542-3548
19. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96(4):1180-1184
20. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340(2):115-126
21. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105(9):1135-1143
22. Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103(13):1813-1818
23. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336(14):973-979
24. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342(12):836-843
25. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E (1998) C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in myocardial infarction. J Am Coll Cardiol 31(7):1460-1465
26. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE (1999) C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon Circulation 100(1):96-102
27. Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, Koenig W, Schmitz G, Hombach V, Torzewski J (2000) C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 20(9):2094-2099
28. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I (2002) Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 106(12):1439-1441
29. Korantzopoulos P, Kolettis T, Siogas K, Goudevenos J (2003) Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 9(9):RA225-RA229
30. Boffa MC, Karmochkine M (1998) Thrombomodulin: an overview and potential implications in vascular disorders. Lupus 7(Suppl 2):S120-S125
31. Seigneur M, Dufourcq P, Conri C, Constans J, Mercie P, Pruvost A, Amiral J, Midy D, Baste JC, Boisseau MR (1993) Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res 71(6):423-431
32. Boffa MC (1996) Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker? Haemostasis 26(Suppl 4):233-243
33. Jansson JH, Boman K, Brannstrom M, Nilsson TK (1996) Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant treatment. Eur Heart J 17(10):1503-1505
34. Yamashita T, Sekiguchi A, Iwasaki YK, Sagara K, Hatano S, Iinuma H, Aizawa T, Fu LT (2003) Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria. Circulation 108(20):2450-2452
35. Pongratz G, Brandt-Pohlmann M, Henneke KH, Pohle C, Zink D, Gehling G, Bachmann K (1997) Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation. Chest 111(4):929-933
36. Young-Xu Y, Jabbour S, Goldberg R, Blatt CM, Graboys T, Bilchik B, Ravid S (2003) Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 92(12):1379-1383